The global Hemostasis Analyzers market was valued at USD 2829.2 Million in 2018 and is expected to reach USD 6304.1 Million by the year 2030, at a CAGR of 10.4%. Hemostasis is the process of how the body prevents bleeding from a cut or injury. The process involves forming a clot to close the hole in the blood vessel and repairing the blood vessel. Hemostasis analyzers are the devices that support medical practitioners in the treatment of patients with an excess bleeding disorder. Hemostasis analyzers measure the clotting mechanisms of hemostasis; they are used primarily to detect clotting deficiencies related to thromboembolytic disease, thrombocytopenia, impaired liver function, hemophilia, von Willebrand disease, and other conditions. They are also used to monitor the effect of drugs such as heparin, oral anticoagulants, and thrombolytic and antiplatelet agents on whole blood, as well as the effects of blood component therapy.
Hemostasis analyzers are handheld devices or benchtop devices, and are sometimes placed on a cart, with a display (usually LCD), a keypad to enter information, and a slot to insert a test strip or sample tube. Some models may have alarms, memory functions, touchpens, USB ports to transfer data to a computer, and a small storage compartment for reagents. There are three principal modes of operation if a hemostasis analyzer. There are three primary modes of operation for these hemostasis analyzers. Mechanical impedance uses blood viscosity changes to determine clotting time. Instruments using the photometric principle monitor changes in the specimen’s optical density to detect the beginning of clot formation. The electromagnetic method uses a magnet in the test tube aligned with a magnetic detector in the cuvette and remains locked in position with the detector while the test tube rotates. When a clot forms, it entangles the magnet, breaking the electromagnetic coupling and allowing the magnet to rotate with the tube, terminating the test.
Request a Sample@ https://qyresearchmedical.com/sample/118997
Continuous technological advancements in the field of medical treatment have led to the development of novel drugs and hemostasis analyzers, which is expected to drive the market during the forecast years. Moreover, rising demand for laboratory automation and increased spending on research and development along with active government initiatives to create awareness regarding bleeding disorders is expected to support the growth of hemostasis analyzers market significantly. Growing geriatric population and increased healthcare spending are some of the factors that support the growth of hemostasis analyzers market. With constant advancements in diagnostic technology and high R&D spending by various major economies for the introduction of advanced instruments such as high throughput hemostasis analyzers, the growth of the global hemostasis analyzers market is seeing an upward swing. In addition to this, the growing consumer awareness towards advanced technologies also supports the growth of hemostasis analyzers market. The improved healthcare infrastructure in developing economies provides growth opportunities for global hemostasis analyzers market too. Also, these countries are witnessing a paradigm shift and are investing huge amount of government funds to acquire and set up advanced diagnostic equipment. All these factors are contributing immensely in the growth of hemostasis analyzers market.
Key Coverage of the Report
- Region and country-wise assessment from the period 2019-2030. For the study, 2019-2017 has been utilized as historical data, 2018 as the base year, and 2019-2030, has been derived as forecasts
- Regional Competitors clinical pipeline analysis of Hemostasis Analyzers industry
- Demand and Supply GAP Analysis
- Market share analysis of the key Hemostasis Analyzers industry players
- Strategic recommendations for the new entrants in the Hemostasis Analyzers marketplace
- Market forecasts for a minimum of 6 years of all the mentioned segments, and the regional markets
- Hemostasis Analyzers Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
Salient Trends of the Hemostasis Analyzers Market
- Launch of new channels systems that can simultaneously test prothrombin, fibrinogen, activated partial thromboplastin time and activated clotting time is expected to propel the market growth in the Test Type segment
- Growing prevalence of bleeding disorders and cardiovascular diseases is expected to drive the market for hemostasis analyzers
- Rising adoption rate of hemostasis analyzers by various diagnostic laboratories and clinics in emerging as well as developed economies is expected to propel the market growth over the forecast years.
- Point-of-care devices used for diagnosis of bleeding disorders are used to support the monitoring of patient oral anticoagulant therapy and vitamin K antagonists and thus provide high sensitivity and improved patient compliance in less time
- The high cost of hemostasis analyzers and slow adoption rate of hemostasis analyzers in developing economies is a major challenge for market growth across the globe
Companies considered and profiled in this market study
Siemens Healthcare, Thermo Fisher Scientific, Instrumentation Laboratory Werfen Group, Sysmex Corporation, Roche Diagnostics, Diagnostica Stago, International Technidyne Corporation, Alere, Sysmex Corporation and Nihon Kohden Corporation
Market-O-Nomics
- As of 2018, Prothrombin Time is the leading sub-segment of the Test Type segment of global Hemostasis Analyzers marke. It is also expected to register the highest CAGR during the forecast period owing to automation in the laboratories
- Research institutes are expected to witness high growth with a significant CAGR of due to the adoption of the latest technologies and increasing research budget
- North America dominates the global hemostasis market with 34.3% market share. This is due to developed healthcare infrastructure, growing research and development activities, and increasing prevalence of hemostasis disorders in the region
- Mechanical hemostasis analyzers market is expected to witness significant growth due to its low cost and high accuracy
- Asia Pacific regional segment is expected to show the highest CAGR of 11.2% amongst all the regions over the forecast period owing to increasing awareness regarding hemostasis in this region
Segments covered in the report
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2019 to 2030. For the purpose of this study, Reports and Data have segmented the Hemostasis Analyzers market on the basis of product, test, technology, end use, and region:
Product (Revenue, USD Million; Volume, Kilo Tons; 2019–2030)
- Clinical laboratory analyzer
- Systems
- Automated Systems
- Semi-Automated Systems
- Manual
- Consumables
- Reagents
- Standards, Controls and Calibrations
- Analyzer for Point-of-care testing
- Systems
Test Type (Revenue, USD Million; Volume, Kilo Tons; 2019–2030)
- Prothrombin Time
- Fibrinogen
- Activated partial Thromboplastin Time
- Activated Clotting Time
- D Dimer
- Platelet Function
- Anti-factor Xa
- Heparin & Protamine response Test for ACT
- Other Coagulation Tests
Technology Type (Revenue, USD Million; Volume, Kilo Tons; 2019–2030)
- Mechanical
- Optical
- Electrochemical
- Other Technologies
End Use (Revenue, USD Million; Volume, Kilo Tons; 2019–2030)
- Diagnostic Centers
- Hospitals
- Research Institutes
- Others
Regional Outlook (Revenue, USD Million; Volume, Kilo Tons; 2019–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/118997/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/